Suli Pharma Production

Accelerating, transforming challenge into success

Process design/development; lab, pilot and commercial scale production

Through an exclusive partnership formally established on Jan 1, 2018, AcceleDev – Suli synergistically combined their strengths in the area of pharmaceutical process design, development and production.

Production Site Facilities

  • The “Suli Group” founded in 1990, and in Dec 2016 reached the China stock market(# 603585); $300 million annual revenue.
  • 36000m2 site, located within the Jiangsu Ligang industrial park, China’s #1 Provincial level park.
  • Designed and governed according to GMP principles. Also, ISO9001, ISO14001, QHSAS18001 certified.
  • EHS system “continuous investment”: $1.35 million in the last 2 years
  • Successfully western pharma audited and “RSM approved.”
  • Staff of 60 on-site, including 7 experienced process development chemists.
  • Production team leader with >20 years of commercial pharma production experience.
  • Well-equipped on-site analytical lab
  • Total volume reactor capacity: 46,000 L.
  • All reactors and processes are monitored / controlled by automated system.
  • 12 fume hoods for process development/optimization study work
  • Large kilo-lab with multiple walk-in fume hoods and 30-100L vessels complete reactor process development/ production set-ups.
  • 30 glass-lined and stainless-steel reactors: 300L to 5000L
  • Production scale temp range: -80 to 280 °C
  • High pressure up to 5MPa (725psi or 50bar)
  • Halar and titanium coated centrifuges and vacuum driers.
  • Large scale chromatography on-site
  • On-site stability testing: accelerated and long-term on-site stability chambers